Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-04-05

Clinical Trial Update: Prospective Trial of Metformin - Chemoprevention Role [NA]

View source ↗

Summary

A trial studying metformin for colorectal cancer chemoprevention has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectum | NA | Status: WITHDRAWN